|
[1]VERNON G, BARANOVA A, YOUNOSSI ZM.Systematic review:The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther, 2011, 34 (3) :274-285.
|
|
[2]WEISS J, RAU M, GEIER A.Non-alcoholic fatty liver disease:Epidemiology, clinical course, investigation, and treatment[J].Dtsch Arztebl Int, 2014, 111 (26) :447-452.
|
|
[3]LU ZY, SHAO Z, LI YL, et al.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population:An 8-year follow-up study[J].World J Gastroenterol, 2016, 22 (13) :3663-3669.
|
|
[4]WONG RJ, AGUILAR M, CHEUNG R, et al.Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J].Gastroenterology, 2015, 148 (3) :547-555.
|
|
[5]WRUCK W, GRAFFMANN N, KAWALA MA, et al.Concise review:Current status and future directions on research related to nonalcoholic fatty liver disease[J].Stem Cells, 2017, 35 (1) :89-96.
|
|
[6]ZHANG QQ, LU LG.Nonalcoholic fatty liver disease:Dyslipidemia, risk for cardiovascular complications, and treatment strategy[J].J Clin Transl Hepatol, 2015, 3 (1) :78-84.
|
|
[7]KATSIKI N, MIKHAILIDIS DP, MANTZOROS CS.Non-alcoholic fatty liver disease and dyslipidemia:An update[J].Metabolism, 2016, 65 (8) :1109-1123.
|
|
[8]VAN ZYL T, JERLING JC, CONRADIE KR, et al.Common and rare single nucleotide polymorphisms in the LDLR gene are present in a black South African population and associate with low-density lipoprotein cholesterol levels[J].J Hum Genet, 2014, 59 (2) :88-94.
|
|
[9]MUALLEM H, NORTH KE, KAKOKI M, et al.Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the atherosclerosis risk in communities study[J].Hum Genet, 2007, 121 (3-4) :421-431.
|
|
[10]PULLINGER CR, HENNESSY LK, CHATTERTON JE, et al.Familial ligand-defective apolipoprotein B.Identification of a new mutation that decreases LDL receptor binding affinity[J].J Clin Invest, 1995, 95 (3) :1225-1234.
|
|
[11]FRANCKE U, BROWN MS, GOLDSTEIN JL.Assignment of the human gene for the low density lipoprotein receptor to chromosome19:Synteny of a receptor, a ligand, and a genetic disease[J].Proc Natl Acad Sci U S A, 1984, 81 (9) :2826-2830.
|
|
[12]SUDHOF TC, GOLDSTEIN JL, BROWN MS, et al.The LDL receptor gene:A mosaic of exons shared with different proteins[J].Science, 1985, 228 (4701) :815-822.
|
|
[13]ZHANG GM, WANG MY, LIU YN, et al.Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility[J].Carcinogenesis, 2017, 38 (12) :1241-1248.
|
|
[14]ANAND SS, XIE C, PARE G, et al.Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups:The INTERHEART genetics study[J].Circ Cardiovasc Genet, 2009, 2 (1) :16-25.
|
|
[15]TAKEUCHI F, ISONO M, KATSUYA T, et al.Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals[J].PLo S One, 2012, 7 (9) :e46385.
|
|
[16]World Medical Association.World Medical Association Declaration of Helsinki:Ethical principles for medical research involving human subjects[J].Jama, 2013, 310 (20) :2191-2194.
|
|
[17]RAZAVIZADE M, JAMALI R, ARJ A, et al.Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease[J].Hepatobiliary Pancreat Dis Int, 2012, 11 (5) :513-520.
|
|
[18]Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
|
|
[19]SOOKOIAN S, CASTANO GO, SCIAN R, et al.Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity[J].Hepatology, 2015, 61 (2) :515-525.
|
|
[20]CHEN JM, FEREC C, COOPER DN.A systematic analysis of disease-associated variants in the 3'regulatory regions of human protein-coding genes I:General principles and overview[J].Hum Genet, 2006, 120 (1) :1-21.
|
|
[21]CONNE B, STUTZ A, VASSALLI JD.The 3'untranslated region of messenger RNA:A molecular'hotspot'for pathology?[J].Nat Med, 2000, 6 (6) :637-641.
|
|
[22]KNOUFF C, MALLOY S, WILDER J, et al.Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform[J].J Biol Chem, 2001, 276 (6) :3856-3862.
|
|
[23]LEE JD, HSIAO KM, WANG TC, et al.Mutual effect of rs688 and rs5925 in regulating low-density lipoprotein receptor splicing[J].DNA Cell Biol, 2014, 33 (12) :869-875.
|
|
[24]CARUZ A, NEUKAM K, RIVERO-JUAREZ A, et al.Association of low-density lipoprotein receptor genotypes with hepatitis C viral load[J].Genes Immun, 2014, 15 (1) :16-24.
|
|
[25]LI XL, SUI JQ, LU LL, et al.Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease:A concise review[J].Lipids Health Dis, 2016, 15:53.
|
|
[26]ONG JP, PITTS A, YOUNOSSI ZM.Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease[J].J Hepatol, 2008, 49 (4) :608-612.
|
|
[27]STEPANOVA M, YOUNOSSI ZM.Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the USpopulation[J].Clin Gastroenterol Hepatol, 2012, 10 (6) :646-650.
|
|
[28]LIU H, LU HY.Nonalcoholic fatty liver disease and cardiovascular disease[J].World J Gastroenterol, 2014, 20 (26) :8407-8415.
|
|
[29]ONI ET, AGATSTON AS, BLAHA MJ, et al.A systematic review:burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver;should we care?[J].Atherosclerosis, 2013, 230 (2) :258-267.
|
DownLoad: